NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-112-2021-0-EP-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases EP National Stage 22732782.2 Issued
NIDDK E-112-2021-0-DE-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases DE EP 22732782.2 Issued
NIDDK E-112-2021-0-FR-01 Vitamin C Renal Leak As A Clinical Diagnostic Tool In The Detection, Monitoring And Management Of Acute And Chronic Diseases FR EP 22732782.2 Issued
NHLBI E-091-2021-0-US-02 SHORT APOC-II MIMETIC PEPTIDES AND METHODS OF USE US National Stage 18/572,462 Pending
NCI E-106-2021-0-EP-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME EP National Stage 22741091.7 Pending
NCATS E-094-2024-0-US-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/612,654 Expired
NCI E-106-2021-0-AU-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME AU National Stage 2022288631 Pending
NEI E-155-2020-0-EP-04 METHODS TO GENERATE MACULAR, CENTRAL AND PERIPHERAL RETINAL PIGMENT EPITHELIAL CELLS EP National Stage 22736412.2 Pending
NCI E-229-2014-0-AU-01 Methods of Isolating T Cells Having Antigenic Specificity for a Cancer-Specific Mutation AU DIV 2023285735 Pending
NIAID E-024-2023-0-PC-01 MONOCLONAL ANTIBODIES FOR TREATING SARS-COV-2 INFECTION PCT PCT PCT/US2023/084255 Expired
NCI E-171-2020-0-HK-01 EXO VII Inhibitor and Quinolone Antibiotic Combination Useful for Treating Bacterial Infection HK EP 62023084208.5 Pending
NIAID E-216-2021-0-EP-01 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS EP National Stage 22825830.7 Pending
NCI E-013-2018-0-JP-01 Fully Human Antibody Targeting Human CD19 For Cancer Therapeutic Development JP DIV 2023-212056 Pending
NCI E-038-2023-1-US-01 BIVALENT COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME US 63/610,555 Abandoned
NCATS E-246-2023-0-US-01 Inhibitors of the Surface Expression of the Voltage-Gated Sodium Ion Channel 1.7 (NaV1.7) and Their Therapeutic Uses US 63/610,632 Expired
NCATS E-262-2023-0-US-01 Triazolone Inhibitors of Nicotinamide N-Methyltransferase and Their Therapeutic Uses US 63/610,682 Expired
NEI E-153-2020-0-EP-06 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells EP National Stage 22732802.8 Issued
NEI E-153-2020-0-GB-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells GB EP 22732802.8 Issued
NEI E-153-2020-0-IT-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells IT EP 22732802.8 Issued
NEI E-153-2020-0-DK-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells DK EP 22732802.8 Issued
NEI E-153-2020-0-FR-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells FR EP 22732802.8 Issued
NEI E-153-2020-0-NL-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells NL EP 22732802.8 Issued
NEI E-153-2020-0-SE-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells SE EP 22732802.8 Issued
NEI E-153-2020-0-CH-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells CH EP 22732802.8 Issued
NEI E-153-2020-0-ES-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells ES EP 22732802.8 Issued
NEI E-153-2020-0-DE-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells DE EP 22732802.8 Issued
NEI E-153-2020-0-BE-01 Biodegradable Tissue Scaffold With Secondary Matrix To Host Weakly Adherent Cells BE EP 22732802.8 Issued
NIAID E-216-2021-0-US-02 Self-Assembling Nanoparticles Based On Amphiphilic Peptides for Drug Delivery Applications US National Stage 18/570,579 Pending
NIAID E-209-2023-0-US-01 Improved Live-Attenuated Vaccines for Respiratory Syncytial Virus (RSV) Bearing Codon-Pair Deoptimized NS1, NS2, N, P, M, SH and L ORFs and Additional Point Mutations US 63/610,282 Expired
NIAID E-216-2021-0-CA-01 Self-assembling Nanoparticles Based On Amphiphilic Peptides For Drug Delivery Applications CA National Stage 3222840 Pending
NIAID E-202-2018-0-US-04 USE OF OUABAIN ANTAGONISTS TO INHIBIT VIRAL INFECTION US CON 18/538,065 Abandoned
NIAID E-216-2021-0-AU-01 SELF-ASSEMBLING NANOPARTICLES BASED ON AMPHIPHILIC PEPTIDES FOR DRUG DELIVERY APPLICATIONS AU National Stage 2022293891 Pending
NIAID E-215-2016-1-US-01 PREFUSION PIV F IMMUNOGENS AND THEIR USE US DIV 18/537,448 12435113 Issued PDF
NEI E-192-2014-1-EP-10 Surgical Tool and Method for Ocular Tissue Transplantation EP DIV 23215832.9 Pending
NCI E-233-2014-0-AU-01 METHODS OF ISOLATING T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION AU DIV 2023282185 Pending
NCATS E-116-2016-0-JP-01 CRYSTAL FORMS AND METHODS OF SYNTHESIS OF (2R, 6R)-HYDROXYNORKETAMINE AND (2S, 6S)-HYDROXYNORKETAMINE JP DIV 2023-208374 Pending
NIA E-249-2016-0-SG-01 METHODS OF DELIVERING A NEUROPROTECTIVE POLYPEPTIDE TO THE CENTRAL NERVOUS SYSTEM AND METHODS OF TREATING A CENTRAL NERVOUS SYSTEM DISEASE SG DIV 10202303473R Pending
NHGRI E-044-2013-1-SG-01 OLIGONUCLEOTIDE ANALOGUES TARGETING HUMAN LMNA SG DIV 10202303471P Pending
CC E-230-2023-0-US-01 HEAR (Healthcare via Electronic and Acoustic Records) US 63/608,703 Expired
NCI E-106-2021-0-US-02 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME US National Stage 18/568,738 Pending
NCI E-148-2021-0-US-02 COMPOSITIONS AND METHODS FOR DETERMINING RESPONSIVENESS TO IMMUNE CHECKPOINT INHIBITORS (ICI), INCREASING EFFECTIVENESS OF ICI, AND TREATING CANCER US National Stage 18/568,661 Pending
NCI E-118-2021-0-CN-01 Cross Species Single Domain Antibodies Targeting PD-L1 For Treating Solid Tumors CN National Stage 202280041531.8 Pending
NHLBI E-127-2021-2-EP-01 COMPOSITIONS AND METHODS FOR TREATING SICKLE CELL DISEASES EP National Stage 22726911.5 Pending
NCI E-106-2021-0-JP-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME JP National Stage 2023-575827 Pending
NCI E-106-2021-0-CA-01 COMPOUNDS THAT BIND NON-CANONICAL G-QUADRUPLEX STRUCTURES AND METHODS OF MAKING AND USING THE SAME CA National Stage 3222837 Pending
NCI E-285-2016-2-AU-01 Glypican 2 As A Cancer Marker And Therapeutic Target AU DIV 2023278110 Pending
NCI E-031-2024-0-US-01 TREATMENT OF ALVEOLAR SOFT PART SARCOMA (ASPS) WITH ATEZOLIZUMAB US 63/608,127 Expired
NIAID E-150-2021-0-PC-01 NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST WESTERN, EASTERN, AND VENEZUELAN EQUINE ENCEPHALITIS VIRUS (EVV) PCT PCT PCT/US2023/082822 Expired
NIAID E-051-2023-0-PC-01 HYDROGEL PURIFICATION OF CELL MATERIALS FOR PCR-ACTIVATED CELL SORTING PCT PCT PCT/US2023/082816 Expired
NIDDK E-033-2023-0-PC-01 Thyclotide Peptide Conjugates With Cell Permeability And Inhibitory Activity PCT PCT PCT/US2023/082871 Expired